Subtype
Large Intestinal Neoplasm
CI-CAN-00001062Explore in graph →
Non-malignant1,846 active trials21 approved drugs383 evidence items
- NCIt
- C215201
Loading cancer entity…
Subtype
CI-CAN-00001062Explore in graph →
Clinical trials
8,846 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00147550 | MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma. | terminated | Phase 1 / Phase 2 | 79 | PfizerINDUSTRY | 1 | Sep 13, 2013 | clinicaltrials |
| NCT00145860 | Do Patients With Colorectal Cancer Understand That Their Family is at Risk? | terminated | — | 650 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00033306 |
| BMS-247550 in Treating Patients With Metastatic Colorectal Cancer |
| terminated |
| Phase 2 |
| 2 |
| University of Alabama at BirminghamOTHER |
| 1 |
| Aug 5, 2013 |
| clinicaltrials |
| NCT00896467 | Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy | terminated | — | 200 | Centre Oscar LambretOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00932724 | CY-503 for the Treatment of Chemotherapy-refractory Metastatic Colorectal Cancer(CY503C2) | terminated | Phase 2 | 77 | Cytavis Biopharma GmbHINDUSTRY | 2 | Jul 10, 2013 | clinicaltrials |
| NCT00398333 | Study to Assess the Effectiveness of a Omega-3 Enriched Supplement on Chemotherapy Tolerance in Colon Cancer Patients | terminated | Phase 4 | 13 | Hospital Clinic of BarcelonaOTHER | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00049608 | Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid Tumors | terminated | Phase 1 | 51 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00908024 | Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors | terminated | Phase 1 / Phase 2 | 54 | Bristol-Myers SquibbINDUSTRY | 2 | Jun 18, 2013 | clinicaltrials |
| NCT01257035 | Predictive Value of 18F-FAZA in Rectum Cancer(FAZA) | terminated | — | 21 | Vejle HospitalOTHER | 1 | Jun 17, 2013 | clinicaltrials |
| NCT00006001 | SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer | terminated | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | Jun 3, 2013 | clinicaltrials |
| NCT01032291 | A Study to Assess the Efficacy and Safety of Lenalidomide in Combination With Cetuximab in Pre-treated Patients With KRAS Mutant Colorectal Cancer | terminated | Phase 2 | 51 | Celgene CorporationINDUSTRY | 6 | May 21, 2013 | clinicaltrials |
| NCT00012246 | Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract | terminated | Phase 2 | 7 | The University of Texas Medical Branch, GalvestonOTHER | 1 | May 16, 2013 | clinicaltrials |
| NCT00268463 | Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer | terminated | Phase 3 | 22 | NSABP Foundation IncNETWORK | 1 | May 15, 2013 | clinicaltrials |
| NCT01189227 | Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery | terminated | Phase 3 | 9 | NSABP Foundation IncNETWORK | 1 | May 10, 2013 | clinicaltrials |
| NCT00006015 | Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced, Recurrent, or Metastatic Colorectal Cancer | terminated | Phase 2 | 26 | National Cancer Institute (NCI)NIH | 1 | May 3, 2013 | clinicaltrials |
| NCT01466504 | Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin | terminated | — | 4 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Apr 15, 2013 | clinicaltrials |
| NCT00004193 | ISIS 2503 in Treating Patients With Metastatic and/or Locally Recurrent Colorectal Cancer | terminated | Phase 2 | 25 | University of Alabama at BirminghamOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT01329809 | Neoadjuvant Study of Recombinant Vaccinia Virus to Treat Metastatic Colorectal Carcinoma in Patients Undergoing Complete Resection of Liver Tumors | terminated | Phase 2 | 2 | Jennerex BiotherapeuticsINDUSTRY | 1 | Apr 10, 2013 | clinicaltrials |
| NCT01318447 | CyberKnife® for Hepatic Metastases From Colorectal Cancer | terminated | Phase 2 | 15 | Accuray IncorporatedINDUSTRY | 3 | Apr 8, 2013 | clinicaltrials |
| NCT00016029 | Comparison of Barium Enema, Computed Tomographic Colonography, and Colonoscopy in Detecting Colon Cancer | terminated | N/A | 775 | Duke UniversityOTHER | 1 | Mar 22, 2013 | clinicaltrials |
| NCT00405561 | Study to Evaluate Progression Free Survival in Cancer Patients With Advanced Colorectal Carcinoma With AMT2003 | terminated | Phase 2 / Phase 3 | 67 | Auron Healthcare GmbHINDUSTRY | 1 | Mar 20, 2013 | clinicaltrials |
| NCT00937482 | Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer | terminated | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 1 | Mar 8, 2013 | clinicaltrials |
| NCT00608595 | Celecoxib in Treating Patients With Early-Stage Rectal Cancer | terminated | N/A | 10 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Mar 5, 2013 | clinicaltrials |
| NCT00889343 | Study to Evaluate the Effects of Sorafenib if Combined With Chemotherapy (FOLFOX6 or FOLFIRI) in the Second-Line Treatment of Colorectal Cancer(FOSCO) | terminated | Phase 2 | 101 | AIO-Studien-gGmbHOTHER | 1 | Mar 4, 2013 | clinicaltrials |
| NCT00950820 | Study to Evaluate the Effects of Panitumumab if Combined With Chemotherapy for 2nd Treatment of Colorectal Cancer(VOXEL) | terminated | Phase 2 | 9 | AIO-Studien-gGmbHOTHER | 1 | Mar 4, 2013 | clinicaltrials |
| NCT00959946 | Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 32 | PfizerINDUSTRY | 6 | Feb 22, 2013 | clinicaltrials |
| NCT00531115 | Phase II Study to Evaluate Safety and Efficacy of Cetuximab in Combination With XELOX for 12 Weeks Followed by Maintenance Treatment With Cetuximab Plus Capecitabine as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer. | terminated | Phase 2 | 28 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | Feb 20, 2013 | clinicaltrials |
| NCT00681876 | Phase II Study of Avastin + Erbitux + Irinotecan as 2nd Line Treatment of Colorectal Cancer | terminated | Phase 2 | 16 | Hellenic Oncology Research GroupOTHER | 1 | Feb 13, 2013 | clinicaltrials |
| NCT00755534 | Irinotecan/Cetuximab Followed by XELOX/Cetuximab vs the Reverse Sequence in Metastatic CRC | terminated | Phase 2 | 68 | Hellenic Oncology Research GroupOTHER | 1 | Feb 13, 2013 | clinicaltrials |
| NCT00002796 | Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer | terminated | Phase 1 / Phase 2 | 46 | National Cancer Institute (NCI)NIH | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00087334 | Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer | terminated | Phase 1 / Phase 2 | 10 | Roswell Park Cancer InstituteOTHER | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00070122 | Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer | terminated | Phase 3 | 2,200 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00070265 | Neoadjuvant and Adjuvant Capecitabine and Oxaliplatin in Treating Patients With Resectable Liver Metastases Secondary to Colorectal Cancer | terminated | Phase 2 | 80 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT01619696 | Prospective Pilot Study of Multimodal Radiological Evaluation Feasibility During Chemoradiotherapy of Rectal Adenocarcinomas | terminated | Phase 2 | 3 | University Hospital, ToulouseOTHER | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00052585 | Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer | terminated | Phase 2 | 50 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00087191 | EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer | terminated | N/A | 30 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00087256 | Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer | terminated | Phase 3 | 18 | NSABP Foundation IncNETWORK | 1 | Jan 7, 2013 | clinicaltrials |
| NCT00288444 | Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer | terminated | Phase 1 | 38 | Emory UniversityOTHER | 1 | Dec 18, 2012 | clinicaltrials |
| NCT00387348 | Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer | terminated | Phase 3 | 24 | Massachusetts General HospitalOTHER | 1 | Dec 3, 2012 | clinicaltrials |
| NCT00609622 | Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer | terminated | Phase 2 | 191 | PfizerINDUSTRY | 4 | Oct 11, 2012 | clinicaltrials |
| NCT00043004 | Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer | terminated | Phase 2 | 119 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 10 | Sep 24, 2012 | clinicaltrials |
| NCT00068744 | Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer | terminated | Phase 2 / Phase 3 | 88 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Sep 24, 2012 | clinicaltrials |
| NCT00828620 | Positron Emission Tomography - Computed Tomography (PET-CT) Cetuximab Project | terminated | — | 21 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Aug 10, 2012 | clinicaltrials |
| NCT00062023 | Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer | terminated | Phase 2 | 12 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT01056809 | Treatment Strategies for Primarily Generalized Colorectal Cancer(PGC) | terminated | N/A | 15 | Vrinnevi HospitalOTHER | 1 | May 31, 2012 | clinicaltrials |
| NCT00006269 | Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer | terminated | Phase 3 | 89 | NovartisINDUSTRY | 1 | May 25, 2012 | clinicaltrials |
| NCT00824161 | Phase II Study of TAS-109 to Treat Advanced Colorectal Cancer | terminated | Phase 2 | 28 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Apr 23, 2012 | clinicaltrials |
| NCT01109615 | Pemetrexed and Gemcitabine for Treatment Resistant Patients With Metastatic Colorectal Cancer and KRAS Mutations(PG) | terminated | Phase 2 | 40 | Vejle HospitalOTHER | 1 | Apr 19, 2012 | clinicaltrials |
| NCT01126450 | Lenalidomide and Cetuximab in Treating Patients With Metastatic Colorectal Cancer | terminated | Phase 1 | 3 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 20, 2012 | clinicaltrials |
| NCT00110721 | GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer | terminated | Phase 2 | 20 | Galectin Therapeutics Inc.INDUSTRY | 2 | Mar 6, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Sep 13, 2013source: clinicaltrials